DI BELLA FOUNDATION
>
DOCUMENTATION INDEX > Patient Area - Documents
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.
(08/04/2011)
Detail
Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
(08/04/2011)
Detail
VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.
(08/04/2011)
Detail
Cancer: antitumor effects of octreotide LAR, a somatostatin analog.
(08/04/2011)
Detail
Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue
(08/04/2011)
Detail
Response of recurrent high-grade glioma to treatmentwith (90)Y-DOTATOC.
(08/04/2011)
Detail
Molecular imaging in thyroid cancer.
(08/04/2011)
Detail
Expression of somatostatin receptors in human melanomacell lines: effect of two different somatostatin analogues, octreotide andSOM230, on cell proliferation.
(08/04/2011)
Detail
Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
(08/04/2011)
Detail
Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge
(08/04/2011)
Detail
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
(08/04/2011)
Detail
[A case of successful treatment using octreotide acetate for occlusive ileus in terminal stage cancer].
(08/04/2011)
Detail
Octreotide LAR: safety and tolerability issues.
(08/04/2011)
Detail
Octreotide treatment of patients with hepatocellular carcinoma--a retrospective single centre controlled study.
(08/04/2011)
Detail
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells.
(08/04/2011)
Detail